ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,311
Screening encounters
1,373
Diagnostic referrals
254
Outstanding pathways
131

Screening pathway

  1. Screening1,373Encounters
  2. Positive finding458Documented findings
  3. Referral254Diagnostic referrals
  4. Follow-up272Diagnostic visits
  5. Outcome123Resolved pathways

Stage totals use different units. Pending pathways: 131. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2025-08-29, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22

Referral-time risk

No matching referral was available at this observation date.

Screened participants

1311 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0286 · Expanded synthetic participant 0286Site A — Urban Referral Hub
EXP-0289 · Expanded synthetic participant 0289Site C — Rural Outreach Programme
EXP-0297 · Expanded synthetic participant 0297Site A — Urban Referral Hub
EXP-0298 · Expanded synthetic participant 0298Site C — Rural Outreach Programme
EXP-0301 · Expanded synthetic participant 0301Site D — Community Engagement Programme
EXP-0304 · Expanded synthetic participant 0304Site B — Peri-Urban Access Programme
EXP-0307 · Expanded synthetic participant 0307Site A — Urban Referral Hub
EXP-0317 · Expanded synthetic participant 0317Site D — Community Engagement Programme
EXP-0323 · Expanded synthetic participant 0323Site B — Peri-Urban Access Programme
EXP-0324 · Expanded synthetic participant 0324Site A — Urban Referral Hub
EXP-0326 · Expanded synthetic participant 0326Site D — Community Engagement Programme
EXP-0327 · Expanded synthetic participant 0327Site E — Resource-Constrained Navigation Programme
EXP-0337 · Expanded synthetic participant 0337Site B — Peri-Urban Access Programme
EXP-0342 · Expanded synthetic participant 0342Site D — Community Engagement Programme
EXP-0343 · Expanded synthetic participant 0343Site A — Urban Referral Hub
EXP-0348 · Expanded synthetic participant 0348Site E — Resource-Constrained Navigation Programme
EXP-0352 · Expanded synthetic participant 0352Site D — Community Engagement Programme
EXP-0353 · Expanded synthetic participant 0353Site B — Peri-Urban Access Programme
EXP-0354 · Expanded synthetic participant 0354Site D — Community Engagement Programme
EXP-0355 · Expanded synthetic participant 0355Site B — Peri-Urban Access Programme
EXP-0356 · Expanded synthetic participant 0356Site B — Peri-Urban Access Programme
EXP-0358 · Expanded synthetic participant 0358Site B — Peri-Urban Access Programme
EXP-0361 · Expanded synthetic participant 0361Site B — Peri-Urban Access Programme
EXP-0365 · Expanded synthetic participant 0365Site A — Urban Referral Hub
EXP-0370 · Expanded synthetic participant 0370Site C — Rural Outreach Programme

Programme insights

Encounters by modality

VIA
592
HPV DNA
587
Cytology
194

Navigation activity

Barrier documented
201
Contact attempt
375
Navigation intervention
85
Diagnostic booking
309
Diagnostic visit
272

Documented barriers

Contact difficulty
64
Transport difficulty
64
Appointment coordination
73

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.